Skip to Main Content

Author Details

Burkert Pieske
Charite University Medicine, Berlin Institute of Health (BIH)
1988
677
91
PMIDPaper TitleJournal TitlePublished Year
37979788Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry.Int J Cardiol2024
37939716Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.ESC Heart Fail2024
36303266Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials.Eur J Heart Fail2023
37804308Proteomic Profiling in Patients With Peripartum Cardiomyopathy: A Biomarker Study of the ESC EORP PPCM Registry.JACC Heart Fail2023
37594484Functional reserve and contractile phenotype of atrial myocardium from patients with atrial remodeling without and with atrial fibrillation.Am J Physiol Heart Circ Physiol2023
37907297Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term follow up of cardiovascular high-risk patients.BMJ Open2023
37522520Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model.Eur J Heart Fail2023
37517939Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.Eur J Intern Med2023
37702315Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex-VAD trial).Eur J Heart Fail2023
37541910Coronary artery disease grading by cardiac CT for predicting outcome in patients with stable angina.J Cardiovasc Comput Tomogr2023
37728907Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.JAMA Cardiol2023
37565973Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.JACC Heart Fail2023
37532426Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.J Am Coll Cardiol2023
35729429German Cardiac Arrest Registry: rationale and design of G-CAR.Clin Res Cardiol2023
37461163Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.Eur J Heart Fail2023
36958632Left-ventricular unloading in extracorporeal cardiopulmonary resuscitation due to acute myocardial infarction - A multicenter study.Resuscitation2023
37123254Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure.Front Physiol2023
37020954Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.iScience2023
37417824Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial.Circ Heart Fail2023
37407731Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial.Clin Res Cardiol2023
37240652Acute Infections and Inflammatory Biomarkers in Patients with Acute Pulmonary Embolism.J Clin Med2023
37403659Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else? The answer may lie in time'.Eur J Heart Fail2023
37138500Pitfalls of mitral regurgitation assessment in the presence of mitral valve prolapse.Echocardiography2023
37070138Biventricular cardiac power reserve in heart failure with preserved ejection fraction.Eur J Heart Fail2023
37031887The Effect of Sacubitril/Valsartan on Left Ventricular Myocardial Deformation in Heart Failure with Preserved Ejection Fraction (PARAMOUNT trial).J Card Fail2023
36994634Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy.Eur J Heart Fail2023
36881394Patient-Reported Frailty and Functional Status in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.JACC Heart Fail2023
36648039Blood-Oxygen-Level Dependent (BOLD) T2-Mapping Reflects Invasively Measured Central Venous Oxygen Saturation in Cardiovascular Patients.JACC Cardiovasc Imaging2023
36844739Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR.Front Cardiovasc Med2023
36684590CMR detects decreased myocardial deformation in asymptomatic patients at risk for heart failure.Front Cardiovasc Med2023
36738846Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.Int J Cardiol2023
36831062G<sub>q</sub>-Mediated Arrhythmogenic Signaling Promotes Atrial Fibrillation.Biomedicines2023
36892488Effect of Training on Vascular Function and Repair in Heart Failure With Preserved Ejection Fraction.JACC Heart Fail2023
34173297Traveling Volunteers: A Multi-Vendor, Multi-Center Study on Reproducibility and Comparability of 4D Flow Derived Aortic Hemodynamics in Cardiovascular Magnetic Resonance.J Magn Reson Imaging2022
37726611CMR findings after COVID-19 and after COVID-19-vaccination-same but different?Int J Cardiovasc Imaging2022
35775383Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology.Eur J Heart Fail2022
35840541Peak O<sub>2</sub> -pulse predicts exercise training-induced changes in peak VÌ¿O<sub>2</sub> in heart failure with preserved ejection fraction.ESC Heart Fail2022
35703355The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.Eur J Heart Fail2022
35369334Case Report: Residual Atrial Shunt Lesions in Aging Adults With Congenital Heart Disease: An Underestimated Risk of Stroke?Front Cardiovasc Med2022
35791083Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial.Eur J Heart Fail2022
35762071First clinical experience of high-power ablation of atrial fibrillation with a novel contact force-sensing gold-tip catheter.Cardiol J2022
35463791Case Series of Potential Cardiac Inflammation Associated With Various SARS-CoV-2 Vaccinations Assessed by Cardiac MRI.Front Cardiovasc Med2022
35393327Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases.BMJ Open2022
35360924Synthetic Extracellular Volume in Cardiac Magnetic Resonance Without Blood Sampling: a Reliable Tool to Replace Conventional Extracellular Volume.Circ Cardiovasc Imaging2022
35656822Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial.Circ Heart Fail2022
35514442Hemodynamic Changes During Physiological and Pharmacological Stress Testing in Patients With Heart Failure: A Systematic Review and Meta-Analysis.Front Cardiovasc Med2022
35747946Impact of different training modalities on high-density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial.ESC Heart Fail2022
35711381Brief Research Report: Quantitative Analysis of Potential Coronary Microvascular Disease in Suspected Long-COVID Syndrome.Front Cardiovasc Med2022
36543361Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.Open Heart2022
36070881Evaluation of the HFA-PEFF Score: results from the prospective DIAST-CHF cohort.ESC Heart Fail2022
  • 1 - 50 of 677

Recommended Authors

Veraprapas Kittipibul
Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 2
Marat Fudim
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 11
Hena Patel
University of Chicago Medical Center
Career Start Year 2008
Number of shared co-authors 1
Oliver Monfredi
University of Virginia Health System
Career Start Year 2008
Number of shared co-authors 0
John W Petersen
University of Florida College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Ayesha Hasan
The Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 5
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 4
Mitsuru Masaki
Division of Clinical Laboratory Medicine, Hyogo College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Eric J Velazquez
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 21
Lee R Goldberg
Hospital of the University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 7
Juan M Aranda
University of Florida
Career Start Year 1997
Number of shared co-authors 3
Naveen L Pereira
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 7
Peter A Brady
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 0
Euan A Ashley
Stanford University
Career Start Year 1993
Number of shared co-authors 8
Lori B Daniels
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 11
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Career Start Year 1991
Number of shared co-authors 34
Vinay Thohan
Mission Hospital
Career Start Year 1989
Number of shared co-authors 11
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 11
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 35
Shawn W Robinson
University of Maryland
Career Start Year 1986
Number of shared co-authors 2
Jalal K Ghali
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 13
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Career Start Year 1984
Number of shared co-authors 12
Patricia A Pellikka
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 5
Francisco Fern??ndez-Avil??s
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 7
Ulf Dahlstr??m
Linkoping University
Career Start Year 1977
Number of shared co-authors 19
Paul Erne
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 4
Dimitrios Th Kremastinos
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 13
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 19
Arthur Mark Richards
National University Heart Centre Singapore
Career Start Year 1964
Number of shared co-authors 21
Ezra A Amsterdam
University of California (Davis) Medical Center
Career Start Year 1961
Number of shared co-authors 14

Collaborators

Carolyn S P Lam
Duke-NUS Medical School
Co-authored papers 46
Florian Blaschke
Co-authored papers 44
Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 27
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 25
Winfried M??rz
Medical Clinic V, University of Heidelberg
Co-authored papers 23
Milton Packer
Co-authored papers 23
Heribert Schunkert
Co-authored papers 18
Adrian F Hernandez
Duke University Medical Center
Co-authored papers 18
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 15
Egbert Bisping
Medical University of Graz
Co-authored papers 14
Kevin J Anstrom
University of North Carolina at Chapel Hill
Co-authored papers 13
Stephane Heymans
Maastricht University Medical Centre
Co-authored papers 12
Alexandre Mebazaa
INSERM UMR-S , Universite de Paris Cite
Co-authored papers 11
Kai-Uwe Eckardt
Co-authored papers 11
Christiane E Angermann
University and University Hospital Wurzburg
Co-authored papers 9
Donald M Bers
Co-authored papers 9
Rudolf A de Boer
Co-authored papers 7
Kenneth Dickstein
University of Bergen
Co-authored papers 7
Junbo Ge
Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
Co-authored papers 6
Thomas Eschenhagen
Co-authored papers 6
Georg Ertl
University Hospital Wurzburg
Co-authored papers 5
Marcus E Kleber
Heidelberg University
Co-authored papers 5
Christian Mueller
University Hospital Basel, University of Basel
Co-authored papers 5
John R Teerlink
Cardiology University of California San Francisco (UCSF)
Co-authored papers 5
Thomas Scheffold
Co-authored papers 4
Lothar A Blatter
Co-authored papers 4
Mariell Jessup
University of Pennsylvania Perelman School of Medicine
Co-authored papers 4
Ramachandran S Vasan
Co-authored papers 4
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 4
Ulrich Kintscher
Co-authored papers 4
Release 1.2